# Borea Therapeutics S.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/borea-therapeutics-s-r-l

- Industry: Biotechnology
- Headquarters: Milan, Italy
- Website: www.boreatherapeutics.com
- Latest round: Seed (Jun 30, 2021)
- Investors on record: 1

## About

Based in Milan, Italy, Borea Therapeutics S.r.l. operates as a biotechnology company developing gene therapies to target specific tissues and cells. The company was Co-founded by Paul Heppenstall and Emblem technology transfer. In June 2021, Borea Therapeutics S.r.l. raised seed funding led by Sofinnova Partners.

The firm offers a gene therapy platform that chemically modifies viral vectors derived from adeno-associated virus (AAV) and alters their tropism and makes them target desired cells and tissues. It is developing gene therapy tools for patients suffering from chronic or genetic diseases.

## Funding rounds

- Seed, Jun 30, 2021 — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed